Moody's Ratings (Moody's) affirmed Laboratory Corporation of America Holdings' ("Labcorp") Baa2 backed senior unsecured debt rating. At the same time, we revised the outlook to stable from positive. The revision of outlook reflects our expectation of the company's continued acquisition-led busines...
A director at Labcorp Holdings Inc sold after exercising options/sold 5,339 shares at 249.230USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...
Moody's Ratings (Moodys) assigned a Baa2 rating to Laboratory Corporation of America Holdings' ("Labcorp") proposed offering of backed senior unsecured notes of up to $1.8 billion. Labcorp intends to use the net proceeds from this offering, along with drawings from a new accounts receivables (A/R) s...
Moody's Ratings (Moody's) affirmed Laboratory Corporation of America Holdings' ("Labcorp") Baa2 senior unsecured debt ratings. At the same time, Moody's revised the outlook to positive from stable. The revision of outlook to positive reflects Moody's expectation that the company will continue its ...
BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance. "Labcorp made important strategic progress this quarter and is well positioned to deliver sustained value and growth,” said Adam Schechter, chairman and CEO of Labcorp. “We are focusing on science, innovation and technology to serve our customers' needs. Our Diagnostics Base Business performed well, and our Drug Development Base Business fundamentals remain strong, despite challenging year-over-year ...
Moody's Investors Service, ("Moody's") affirmed Laboratory Corporation of America Holdings' ("Labcorp") Baa2 senior unsecured rating. The outlook is stable. The affirmation of the Baa2 rating follows Labcorp's announcement on July 28, 2022 that it plans to spin off its clinical development busines...
The independent financial analyst theScreener just lowered the general evaluation of LAB CORP OF AMERICA (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered defensive. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Neutral. As of the analysis date January 14, 2022, the closing price was USD 276.08 and...
Announcement: Moody's Labcorp's initiatives to enhance shareholder value has no effect on ratings. Global Credit Research- 10 Dec 2021. New York, December 10, 2021-- Moody's Investors Service said that Laboratory Corporation of America Holdings' initiatives to enhance shareholder value do not affect Labcorp's Baa2 senior unsecured notes rating or stable outlook.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Laboratory Corporation of America Holdings. Global Credit Research- 10 Dec 2021. New York, December 10, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Laboratory Corporation of America Holdings and other ratings that are associated with the same analytical unit.
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Rating Action: Moody's assigns Baa2 rating to Labcorp notes offering. Global Credit Research- 12 May 2021. New York, May 12, 2021-- Moody's Investors Service assigned a Baa2 rating to the proposed offering of senior unsecured notes of Laboratory Corporation of America Holdings.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Laboratory Corporation of America Holdings. Global Credit Research- 03 Feb 2021. New York, February 03, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Laboratory Corporation of America Holdings and other ratings that are associated with the same analytical unit.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.